PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $306 | -27.3% | 33 | 0.0% | 0.00% | – |
Q4 2023 | $421 | -76.8% | 33 | -81.2% | 0.00% | – |
Q3 2023 | $1,818 | -91.3% | 176 | -88.9% | 0.00% | – |
Q2 2023 | $20,792 | -19.7% | 1,586 | -31.5% | 0.00% | – |
Q1 2023 | $25,893 | +337.5% | 2,316 | +229.9% | 0.00% | – |
Q4 2022 | $5,918 | -15.5% | 702 | +75.5% | 0.00% | – |
Q3 2022 | $7,000 | 0.0% | 400 | -14.2% | 0.00% | – |
Q2 2022 | $7,000 | -30.0% | 466 | +23.6% | 0.00% | – |
Q1 2022 | $10,000 | -80.4% | 377 | -76.3% | 0.00% | – |
Q4 2021 | $51,000 | +37.8% | 1,590 | +54.4% | 0.00% | – |
Q3 2021 | $37,000 | +68.2% | 1,030 | +107.7% | 0.00% | – |
Q2 2021 | $22,000 | – | 496 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
Yu Fan | 303,030 | $13,861,000 | 36.18% |
ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
Miura Global Management | 405,000 | $18,525,000 | 3.31% |
GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |